Renal Denervation for Resistant Hypertension

 

Learning Objectives :

•Pathophysiology of Essential and Resistant Hypertension (RH)

•Background and Clinical Trial Evidence for Renal Denervation (RDN)

•Proposed Pathway for Incorporating RDN into Clinical Practice in 2025

•Knowledge gaps and future research opportunities

Session date: 
02/27/2025 - 12:30pm to 1:30pm EST
Location: 
Virtual
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

Please login or register to take this course.
Faculty List: 
Program Director(s)

Jay Potluri

has no relevant financial relationships to disclose at this time.
Speaker(s)

Behnam Tehrani, Co-Director, Cardiac Catheterization Labs, IFMC

has no relevant financial relationships to disclose at this time.